About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Browse journal metrics
Showing records 7,871–7,880 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 7,420 |
Taiwanese Journal of Obstetrics & Gynecology TAIWAN J OBSTET GYNE |
1028-4559 N/A |
2.200 | 1.900 | Q2 | 49/140 | ELSEVIER TAIWAN |
| 7,420 |
Team Performance Management TEAM PERFORM MANAG |
1352-7592 1758-6860 |
2.200 | 2.300 | Q3 | 251/420 | EMERALD GROUP PUBLISHING LTD |
| 7,420 |
TETRAHEDRON TETRAHEDRON |
0040-4020 1464-5416 |
2.200 | 1.900 | Q2 | 25/57 | PERGAMON-ELSEVIER SCIENCE LTD |
| 7,420 |
Therapeutic Advances in Cardiovascular Disease THER ADV CARDIO DIS |
1753-9447 1753-9455 |
2.200 | 2.900 | Q2 | 111/230 | SAGE PUBLICATIONS LTD |
| 7,420 |
Therapeutic Delivery THER DELIV |
2041-5990 2041-6008 |
2.200 | 3.500 | Q3 | 209/352 | TAYLOR & FRANCIS LTD |
| 7,420 |
Therapeutics and Clinical Risk Management THER CLIN RISK MANAG |
N/A 1178-203X |
2.200 | 2.500 | Q2 | 90/185 | DOVE MEDICAL PRESS LTD |
| 7,420 |
Thrombosis Journal THROMB J |
1477-9560 1477-9560 |
2.200 | 2.500 | Q3 | 50/98 | BMC |
| 7,420 |
Tobacco Prevention & Cessation TOB PREV CESS |
N/A 2459-3087 |
2.200 | 1.900 | Q3 | 30/58 | EUROPEAN PUBLISHING |
| 7,420 |
Tobacco Use Insights TOB USE INSIGHTS |
1179-173X 1179-173X |
2.200 | 1.900 | Q2 | 183/419 | SAGE PUBLICATIONS LTD |
| 7,420 |
Tomography TOMOGRAPHY |
2379-1381 2379-139X |
2.200 | 2.200 | Q2 | 100/212 | MDPI |